US Ex Rel. Alexander Volkhoff v. Janssen Pharmaceutica N.V. ( 2020 )


Menu:
  •                       FOR PUBLICATION
    UNITED STATES COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    UNITED STATES ex rel. ALEXANDER                     No. 18-55643
    VOLKHOFF, LLC,
    Plaintiff-Appellant, *                 D.C. No.
    2:16-cv-06997-
    v.                             RGK-RAO
    JANSSEN PHARMACEUTICA N.V.;
    JANSSEN PHARMACEUTICALS, INC.;                        OPINION
    JANSSEN RESEARCH AND
    DEVELOPMENT, LLC; JOHNSON &
    JOHNSON; ORTHO-MCNEIL,
    Defendants-Appellees.
    Appeal from the United States District Court
    for the Central District of California
    R. Gary Klausner, District Judge, Presiding
    Argued and Submitted November 14, 2019
    Pasadena, California
    Filed January 2, 2020
    *
    The caption’s reference to Alexander Volkhoff, LLC as “Plaintiff-
    Appellant” reflects the appeal-initiating documents. As we explain
    herein, Alexander Volkhoff, LLC is neither a plaintiff in this action nor
    a proper appellant of the district court order at issue on appeal.
    2    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    Before: FERDINAND F. FERNANDEZ, MILAN D.
    SMITH, JR., and ERIC D. MILLER, Circuit Judges.
    Opinion by Judge Milan D. Smith, Jr.
    SUMMARY **
    Qui Tam / Appellate Jurisdiction
    The panel dismissed for lack of jurisdiction Alexander
    Volkhoff, LLC’s appeal from the dismissal of a first
    amended qui tam complaint filed by relator Jane Doe
    pursuant to the False Claims Act and state false claims laws.
    The panel held that this court lacks jurisdiction to hear
    nonparty Volkhoff’s appeal, where Volkhoff, which
    substituted itself out when Jane Doe filed the first amended
    complaint, chose not to participate in the district court
    proceedings; and where Volkhoff failed to show that the
    equities favor hearing its appeal.
    The panel rejected Volkhoff’s argument that this court
    should infer from the notice of appeal that Jane Doe – a party
    in the district court proceedings – intended to appeal. The
    panel wrote that it is not clear from the notice, as required by
    Fed. R. App. P. 3(c), that Jane Doe intended to appeal. The
    panel rejected the proposition that Volkhoff, an LLC, is
    interchangeable with Jane Doe, a natural person; and wrote
    that the record undermines Volkhoff’s argument that
    **
    This summary constitutes no part of the opinion of the court. It
    has been prepared by court staff for the convenience of the reader.
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA                       3
    Volkhoff’s failure to name Jane Doe as an appellant was an
    inadvertent omission.
    COUNSEL
    C. Brooks Cutter (argued) and John R. Parker, Jr., Cutter
    Law P.C., Sacramento, California; Audra Ibarra, Law Office
    of Audra Ibarra, Palo Alto, California; Mychal Wilson, Law
    Offices of Mychal Wilson, Santa Monica, California; for
    Plaintiff-Appellant.
    Michael A. Schwartz (argued) and Erin Colleran, Pepper
    Hamilton LLP, Philadelphia, Pennsylvania; Jeffrey M.
    Goldman, Pepper Hamilton LLP, Los Angeles, California;
    for Defendants-Appellees.
    OPINION
    M. SMITH, Circuit Judge:
    Alexander Volkhoff, LLC (Volkhoff) appeals the district
    court’s dismissal of the qui tam complaint filed by relator
    Jane Doe pursuant to the False Claims Act (FCA), 
    31 U.S.C. §§ 3729
    –3733, and analogous state false claims laws. 1
    However, Volkhoff was not a party to Jane Doe’s complaint.
    Moreover, it is not clear from Volkhoff’s notice of appeal
    (Notice), as required by Federal Rule of Appellate Procedure
    1
    In a qui tam action brought pursuant to the FCA, a private plaintiff,
    referred to as a “relator,” initiates a suit on behalf of the government for
    alleged fraud. See 
    31 U.S.C. § 3730
    ; United States ex rel. Eisenstein v.
    City of New York, 
    556 U.S. 928
    , 932 (2009). Herein, we use “relator,”
    except where necessary to indicate that the parties used (or did not use)
    the term “plaintiff.”
    4    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    3(c), that Jane Doe also sought to take an appeal. Because
    Volkhoff is a nonparty that cannot appeal, and Jane Doe was
    not properly named as an appellant, we dismiss this appeal
    for lack of appellate jurisdiction.
    FACTUAL AND PROCEDURAL BACKGROUND
    On September 16, 2016, shortly after its incorporation as
    a Delaware limited liability company, Volkhoff filed a qui
    tam complaint (the Original Complaint) in federal district
    court. The Original Complaint named Volkhoff as the
    relator and alleged violations of the FCA and various states’
    false claims laws by Defendants Janssen Pharmaceutica
    N.V., Janssen Pharmaceuticals, Inc., Janssen Research &
    Development, LLC, Johnson & Johnson, and Ortho-McNeil
    (Defendants). In particular, the Original Complaint alleged
    that Defendants fraudulently and unlawfully marketed their
    medications. Neither the United States nor any state elected
    to intervene, allowing Volkhoff to proceed with the Original
    Complaint. 2
    Following Defendants’ motion to dismiss the Original
    Complaint, Volkhoff did not oppose the motion. Instead,
    Volkhoff’s counsel filed a First Amended Complaint (FAC).
    The FAC alleged the same claims as those Volkhoff alleged
    in the Original Complaint. The FAC, however, removed
    2
    FCA suits are subject to certain procedural requirements, including
    the government’s sole right to intervene, generally within 60 days of the
    suit’s filing. See 
    31 U.S.C. § 3730
    ; Eisenstein, 
    556 U.S. at 932
    . Like
    the FCA, the state false claims laws invoked by the Original Complaint
    provide their respective state governments with an opportunity to
    intervene. See, e.g., Cal. Gov’t Code §§ 12650–12656; 
    Colo. Rev. Stat. §§ 25.5-4-303
    .5–25.5-4-310. Because we dismiss this appeal for lack of
    appellate jurisdiction, we do not reach any other procedural issues
    relating to qui tam suits that are raised on appeal.
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA             5
    Volkhoff as the relator and named Jane Doe, an anonymous
    natural person, as the only relator.
    The FAC did not mention Volkhoff or its relationship to
    Jane Doe. In filings before the district court and our court,
    Jane Doe and Volkhoff acknowledge that the replacement of
    Volkhoff by Jane Doe was a tactical decision aimed at
    avoiding the dismissal of the Original Complaint’s FCA
    employment retaliation claim. The change responded to
    Defendants’ first motion to dismiss, which argued that
    Volkhoff, as a limited liability company, lacked standing to
    assert an FCA retaliation claim.
    Defendants moved to dismiss Jane Doe’s FAC. The
    district court dismissed the FAC on April 19, 2018. In
    relevant part, the district court dismissed Jane Doe’s FCA
    claims for lack of subject matter jurisdiction based on the so-
    called “first-to-file bar,” which prevents private third parties
    from intervening in or filing similar FCA qui tam lawsuits
    after an initial relator has filed one. See 31 U.S.C.
    3730(b)(5); United States ex rel. Lujan v. Hughes Aircraft
    Co., 
    243 F.3d 1181
    , 1187 (9th Cir. 2001). In concluding that
    the first-to-file bar applied, the district court found that Jane
    Doe was not a party to the Original Complaint that Volkhoff
    had filed, and that she and Volkhoff were distinct legal
    persons. The district court dismissed Jane Doe’s FCA
    employment retaliation claim because she failed to
    demonstrate a need for proceeding anonymously. Finally,
    the court declined to exercise supplemental jurisdiction over
    Jane Doe’s remaining state law claims and dismissed those
    claims without prejudice.
    Within thirty days of the dismissal, Volkhoff filed the
    Notice challenging the district court’s order. Fed. R. App.
    P. 4. The Notice names Volkhoff as the sole relator and
    plaintiff. It does not mention Jane Doe, nor refer to any other
    6   U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    relator, plaintiff, or appellant.     The “Representation
    Statement” filed concurrently with the Notice, and
    subsequent papers filed with this court, designate Volkhoff
    variously as the only relator, plaintiff, or appellant. On
    appeal, Volkhoff contends that Jane Doe is Volkhoff’s sole
    owner.
    JURISDICTION AND STANDARD OF REVIEW
    Generally, we have jurisdiction over appeals “from all
    final decisions of the district courts of the United States,”
    
    28 U.S.C. § 1291
    , such as the district court’s final decision
    dismissing Jane Doe’s FAC.
    However, whether a nonparty has the ability to appeal is
    a jurisdictional question, see Cal. Dep’t of Toxic Substances
    Control v. Com. Realty Projects, Inc., 
    309 F.3d 1113
    , 1121
    (9th Cir. 2002), and a failure to comply with the filing and
    content requirements of the Federal Rules of Appellate
    Procedure may “present a jurisdictional bar to appeal.” Le
    v. Astrue, 
    558 F.3d 1019
    , 1021, 1024 (9th Cir. 2009). As a
    result, our inquiry into whether this appeal is proper is
    jurisdictional. “We have jurisdiction to determine our own
    jurisdiction.” Havensight Capital LLC v. Nike, Inc., 
    891 F.3d 1167
    , 1171 (9th Cir. 2018) (quoting Agonafer v. Sessions,
    
    859 F.3d 1198
    , 1202 (9th Cir. 2017)). We review whether
    we have appellate jurisdiction de novo. Le, 
    558 F.3d at
    1021
    (citing Perez-Martin v. Ashcroft, 
    394 F.3d 752
    , 756 (9th Cir.
    2005)).
    ANALYSIS
    Volkhoff argues both that it and Jane Doe appealed the
    district court’s dismissal, and that, under either
    circumstance, the appeal is proper. However, Volkhoff and
    Jane Doe each face distinct jurisdictional problems that
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA             7
    foreclose this appeal. First, Volkhoff’s appeal violates the
    general rule that only parties to a lawsuit may appeal it.
    Second, because Volkhoff’s Notice does not name Jane Doe
    or otherwise refer to her, Jane Doe’s purported appeal does
    not conform to Federal Rule of Appellate Procedure 3(c).
    We discuss each jurisdictional defect in turn.
    I.      Volkhoff’s Nonparty Appeal
    Volkhoff claims that it may appeal the dismissal of Jane
    Doe’s FAC even though it was not a party to her lawsuit.
    “The rule that only parties to a lawsuit, or those that properly
    become parties, may appeal an adverse judgment, is well
    settled.” Marino v. Ortiz, 
    484 U.S. 301
    , 304 (1988) (per
    curiam) (citing United States ex rel. Louisiana v. Jack,
    
    244 U.S. 397
    , 402 (1917); Fed. R. App. P. 3(c)). This rule
    echoes the requirements of standing. See Raley v. Hyundai
    Motor Co., Ltd., 
    642 F.3d 1271
    , 1274 (10th Cir. 2011)
    (“After all, it is usually only parties who are sufficiently
    aggrieved by a district court’s decision that they possess
    Article III and prudential standing to be able to pursue an
    appeal of it.” (emphasis added) (citations omitted)). But
    while the rule is sometimes described as “standing to
    appeal,” it is distinct from the requirements of constitutional
    standing. See United States v. Kovall, 
    857 F.3d 1060
    , 1068–
    69 (9th Cir. 2017); In re Proceedings Before Fed. Grand
    Jury, 
    643 F.2d 641
    , 642–643, 642 n.1 (9th Cir. 1981).
    As required by this rule, we hear nonparties’ appeals
    only in “exceptional circumstances.” S. Cal. Edison Co. v.
    Lynch, 
    307 F.3d 794
    , 804 (9th Cir. 2002) (quoting Citibank
    Int’l v. Collier-Traino, Inc., 
    809 F.2d 1438
    , 1441 (9th Cir.
    1987)). “We have allowed such an appeal only when (1) the
    appellant, though not a party, participated in the district court
    proceedings, and (2) the equities of the case weigh in favor
    of hearing the appeal.” Hilao v. Estate of Marcos, 
    393 F.3d 8
      U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    987, 992 (9th Cir. 2004) (citation and internal quotation
    marks omitted); see also United States v. Badger, 
    930 F.2d 754
    , 756 (9th Cir. 1991).
    The cases in which we have applied this test illustrate the
    level and nature of participation in the district court
    proceedings that is required for a nonparty to be permitted to
    appeal. We have allowed nonparties to appeal when they
    were significantly involved in the district court
    proceedings—often because they were compelled to
    participate by one of the parties or the court. Commodity
    Futures Trading Comm’n v. Topworth Int’l, Ltd., 
    205 F.3d 1107
    , 1113–14 (9th Cir. 1999), as amended (9th Cir. 2000)
    (nonparty “participated in the proceedings below to the full
    extent possible” and “participated for several years, rather
    than coming in at the end of the proceedings” (citation
    omitted)); Keith v. Volpe, 
    118 F.3d 1386
    , 1389–91 (9th Cir.
    1997) (after objecting, nonparty responded to order to show
    cause filed by party, filed memorandum of points and
    authorities at court’s request, and participated in oral
    argument); S.E.C. v. Wencke, 
    783 F.2d 829
    , 834–35 (9th Cir.
    1986) (nonparty appeared in the district court to contest the
    same issues it was asserting on appeal, the district court
    accepted nonparty’s briefs, and it allowed him to cross-
    examine witnesses). This requirement is in accordance with
    the Supreme Court’s admonition in Marino that “the better
    practice is for . . . a nonparty to seek intervention for
    purposes of appeal.” 
    484 U.S. at 304
    ; see also Fed. R. Civ.
    P. 24.
    In contrast, we have denied nonparties the right to appeal
    when they choose not to meaningfully involve themselves in
    the district court proceedings. In Citibank, we dismissed a
    nonparty’s appeal from a judgment when the nonparty “was
    well-apprised of the proceedings” but “chose not to
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA           9
    intervene, join or make an appearance to contest jurisdiction
    [in district court], even though it had actual knowledge of the
    proceedings and their substance.” 
    809 F.2d at 1441
    ; see also
    Washoe Tribe v. Greenley, 
    674 F.2d 816
    , 818–19 (9th Cir.
    1982) (concluding that nonparty state could not appeal
    where, by deciding not to intervene in the district court, it
    avoided waiving its immunity).
    We conclude that Volkhoff’s participation in the district
    court proceedings cannot serve as the basis for a right to
    appeal. Its activity in the case all but ceased with the filing
    of the FAC. The substitution of Jane Doe in place of
    Volkhoff was a strategic choice. See Citibank, 
    809 F.2d at 1441
    . Although Volkhoff, in what appears to be a
    scrivener’s error, was listed as the only relator in the
    opposition to Defendants’ motion to dismiss the FAC, the
    district court’s order dismissing the FAC explicitly noted
    that Volkhoff had been substituted out of the lawsuit by Jane
    Doe. Moreover, the district court’s application of the first-
    to-file bar to dismiss the FAC was premised upon on its
    finding that Volkhoff, the initial sole relator, had been
    completely replaced by Jane Doe, the second sole relator.
    Like the nonparty in Citibank, Volkhoff “chose not to
    participate” in the district court proceedings and instead
    substituted itself out when Jane Doe filed the FAC. 
    Id.
    We also find that Volkhoff fails to show that the equities
    favor hearing its appeal. The equities will support a
    nonparty’s appeal “when a party has haled the non-party into
    the proceeding against his will, and then has attempted to
    thwart the nonparty’s right to appeal by arguing that he lacks
    standing or when judgment has been entered against the
    nonparty.” Hilao, 393 F.3d at 992 (citations and internal
    quotation marks omitted); see also Commodity Futures
    Trading Comm’n, 205 F.3d at 1114 n.1 (nonparty was
    10 U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    “brought into the proceedings by the Receiver’s notice
    indicating that [nonparty] would forfeit his right to recover
    anything . . . unless he filed a claim, and by the later schedule
    requiring him to file a written objection or waive it”); Keith,
    
    118 F.3d at 1391
    ; Badger, 
    930 F.2d at 756
    .
    Here, Volkhoff was not haled into court by one of the
    parties or the court. Instead, its participation ceased after it
    made the tactical decision to substitute Jane Doe for itself.
    See Washoe, 
    674 F.2d at
    818–819 (concluding that equities
    did not favor appeal of party that avoided appearing in
    district court). Moreover, the district court’s judgment is
    against Jane Doe, not Volkhoff. At most, Volkhoff
    concludes, with little support, that its appeal is not
    inequitable to Defendants, which does not meet its burden as
    a nonparty appellant to demonstrate that the equities are in
    its favor. See S. Cal. Edison Co., 
    307 F.3d at 804
    . 3 Thus,
    we conclude that we lack jurisdiction to hear nonparty
    Volkhoff’s appeal of the district court’s dismissal of Jane
    Doe’s FAC.
    II.       Jane Doe’s Purported Appeal
    Alternatively, Volkhoff argues that we should infer from
    the Notice that Jane Doe, a party in the district court
    proceedings, intended to appeal. Federal Rule of Appellate
    3
    Volkhoff briefly raises the possibility that Defendants might later
    argue, in a subsequent lawsuit, that the district court’s dismissal of Jane
    Doe’s FAC has a preclusive effect against Volkhoff. The cases that
    Volkhoff relies on to argue that this consideration should affect our
    analysis are inapposite. American Games, Inc. v. Trade Products, Inc.
    concerned an intervenor. 
    142 F.3d 1164
    , 1166 (9th Cir. 1998). Wencke,
    described above, involved a nonparty that was extensively involved at
    the district court. 
    783 F.2d 829
    , 834–835. Furthermore, we do not see
    how the possibility of future legal arguments regarding issue or claim
    preclusion tips the balance of equities in Volkhoff’s favor.
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA 11
    Procedure 3(c) governs the required contents of a notice of
    appeal. Smith v. Barry, 
    502 U.S. 244
    , 247–48 (1992). Rule
    3(c) requires that the notice “specify the party or parties
    taking the appeal by naming each one in the caption or body
    of the notice, but an attorney representing more than one
    party may describe those parties with such terms as ‘all
    plaintiffs,’ ‘the defendants,’ ‘the plaintiffs A, B, et al.,’ or
    ‘all defendants except X.’” Fed. R. App. P. 3(c)(1)(A).
    Rule 3(c), however, instructs us not to dismiss an appeal
    “for failure to name a party whose intent to appeal is
    otherwise clear from the notice [of appeal].” Fed. R. App.
    P. 3(c)(4). The Advisory Committee Note to the 1993
    amendment to Rule 3(c) makes clear that its current version
    aims “to prevent the loss of a right to appeal through
    inadvertent omission[s]” of party names on the notice of
    appeal, but also that it still requires that it be “objectively
    clear that a party intended to appeal.”
    In interpreting Rule 3(c), the Supreme Court has
    instructed that “[a]lthough courts should construe Rule 3
    liberally when determining whether it has been complied
    with, noncompliance is fatal to an appeal.” Le, 
    558 F.3d at 1022
     (quoting Smith, 
    502 U.S. at 248
    ) (brackets in
    original). In particular, we interpret Rule 3(c)(1)(A)’s
    appellant-naming requirements strictly, following the
    Supreme Court’s decision in Torres v. Oakland Scavenger
    Co., 
    487 U.S. 312
     (1988), superseded by statute as
    recognized in Retail Flooring Dealers of America, Inc. v.
    Beaulieu of America, LLC, 
    339 F.3d 1146
    , 1148 (9th Cir.
    2003).
    In Torres, the Court dismissed an appeal pursuant to
    Rule 3(c) because the appellant was not named in the notice
    of appeal. Torres, 
    487 U.S. at
    314−18. Although the 1993
    amendments to Rule 3(c) responded to Torres by allowing
    12 U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    appellants more flexibility in meeting its requirements,
    Retail Flooring, 
    339 F.3d at 1148
    , Torres nevertheless
    continues to guide our interpretation of Rule 3(c). Le,
    
    558 F.3d at 1022
     (“[T]he ‘failure to name a party in a notice
    of appeal is more than excusable “informality,”’ but rather
    ‘it constitutes a failure of that party to appeal.’” (quoting
    Torres, 
    487 U.S. at 314
    )); Argabright v. United States,
    
    35 F.3d 472
    , 474 (9th Cir. 1994) (applying Torres to dismiss
    appeals of appellants not named or implicitly indicated
    through the use of “et al.” or “plaintiffs” in the notice of
    appeal), superseded by statute on other grounds as
    recognized in Hinck v. United States, 
    550 U.S. 501
    , 504
    (2007); see also West v. United States, 
    853 F.3d 520
    , 522–
    24 (9th Cir. 2017) (contrasting our court’s liberal
    interpretation of Rule 3(c)(1)(B) with the Supreme Court’s
    “narrow application of Rule 3(c)(1)(A)” in Torres (citing Le,
    
    558 F.3d at 1022
    )).
    We are not alone in relying on Torres to find that the
    failure to name an appellant in a notice of appeal can result
    in dismissal. The Tenth Circuit relied on Torres in
    dismissing an appeal in a case that we find to be on point. In
    Raley, the initial plaintiff, Misty Raley, asked the district
    court to substitute her for the entity BancFirst as the sole
    plaintiff in the case. 
    642 F.3d at
    1273–74. The court granted
    the requested substitution. 
    Id.
     Defendant Hyundai prevailed
    at trial, but the district court’s judgment erroneously
    identified Raley as the losing plaintiff. 
    Id. at 1274
    . After
    Raley appealed the judgment in her name, the district court
    entered an amended judgment identifying only BancFirst as
    the losing party. 
    Id.
     Raley filed another notice of appeal,
    again in her name, to appeal the amended judgment. 
    Id.
    The Tenth Circuit, quoting Torres for the proposition
    that Rule 3(c) was part of a “jurisdictional threshold” to
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA 13
    appellate review, dismissed the appeal. 
    642 F.3d at 1274, 1276
     (quoting 
    487 U.S. at 315
    ). The Tenth Circuit refused
    to look beyond the notice of appeal to determine whether
    BancFirst intended to appeal. Id. at 1277. Because the
    notice specified only Raley as the appellant and did not “use
    terms that objectively and clearly encompass[ed]”
    BancFirst, the court would not infer that BancFirst intended
    to appeal. Id. Although the court noted the apparent
    harshness of the result, it emphasized that “[t]hroughout
    most of the briefing of [the] appeal it was unclear whether
    BancFirst wanted to pursue an appeal,” creating an unfair
    situation for Hyundai, which “ha[d] to write its briefs and
    prepare its arguments without any way of being sure who
    [was], and who [was] not, seeking to undo its district court
    victory.” Id. at 1278.
    The defects in Volkhoff’s Notice are akin to those in
    Raley’s notice of appeal. It is not clear from the Notice that
    Jane Doe intended to appeal the district court’s dismissal.
    As already discussed, the Notice does not mention Jane Doe
    or her alleged ownership of Volkhoff, and instead designates
    Volkhoff as the only relator, plaintiff, and appellant.
    Perhaps in light of this notable absence, Volkhoff urges
    us to view “Alexander Volkhoff, LLC” and “Jane Doe” as
    interchangeable. We do not accept the proposition that an
    LLC is interchangeable with a natural person. See, e.g.,
    6 Del. Code tit. 6, §§ 18-201(b), 18-303(a); In re Carlisle
    Etcetera LLC, 
    114 A.3d 592
    , 605 (Del. Ch. 2015) (observing
    that the “core attributes of the LLC” include “its separate
    legal existence . . . and limited liability for its members”
    (citation omitted)). Moreover, the alleged unity of identity
    between Volkhoff and Jane Doe is not clear from the Notice.
    Volkhoff also argues that Rule 3(c), as amended in 1993,
    precludes dismissal because the Notice mistakenly named
    14 U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA
    Volkhoff as the relator. The record undermines this
    argument. Before the district court, Jane Doe indicated that
    she changed the relator’s name from “Alexander Volkhoff
    LLC” to “Jane Doe” to maintain the FAC’s FCA
    employment retaliation claim, which could only be brought
    by an individual. In its appeal, Volkhoff acknowledges that
    the decision to switch relators in the FAC was tactical. In
    the shadow of this tactical choice, Volkhoff filed the Notice,
    which failed to designate Jane Doe as an appellant. That
    omission has been repeated in subsequent filings since the
    Notice. We cannot accept that Volkhoff’s failure to name
    Jane Doe as an appellant was an “inadvertent omission” that
    Rule 3(c) requires us to overlook. Fed. R. App. P. 3(c)
    advisory committee’s note to 1993 amendment.
    Finally, Volkhoff relies on Rule 3(c)(4), which instructs
    us not to dismiss an appeal “for failure to name a party whose
    intent to appeal is otherwise clear from the notice.” But Jane
    Doe’s intent to appeal is not clear from the Notice, nor would
    it be any clearer even if we were permitted to look beyond
    the Notice. The lack of identity between Doe and Volkhoff
    was the central merits problem before the district court. The
    fact that Volkhoff is not Doe, and vice versa, is precisely
    why the district court dismissed Doe’s FCA claim in the first
    place—and even before that, why Volkhoff voluntarily
    substituted itself out of the case so that Doe could pursue her
    retaliation claim. Under these circumstances, we cannot find
    that Jane Doe’s intent to appeal was clear when Volkhoff,
    and only Volkhoff, filed a Notice.
    The cases on which Volkhoff relies that invoke Rule
    3(c)(4) involve attorneys who mistakenly appealed sanctions
    orders in the names of their parties, when the attorneys
    signed and were otherwise named in the filings. See
    Detabali v. St. Luke’s Hosp., 
    482 F.3d 1199
    , 1204 (9th Cir.
    U.S. EX REL. VOLKHOFF V. JANSSEN PHARMACEUTICA 15
    2007) (attorney “prepared, signed, and filed Detabali’s
    notice of appeal” challenging sanctions order); Retail
    Flooring, 
    339 F.3d at 1149
     (notice directly challenged
    sanctions against counsel, counsel’s name appeared on the
    notice as the attorney, and counsel signed and filed the notice
    of appeal); Aetna Life Ins. Co. v. Alla Med. Servs., Inc.,
    
    855 F.2d 1470
    , 1473 (9th Cir. 1988) (attorney listed on
    notice of appeal, where only appealable order was that
    imposing sanctions against attorney).          None of the
    considerations that underlie these cases’ applications of Rule
    3(c)(4) applies here. Jane Doe is not serving as Volkhoff’s
    attorney, is not otherwise mentioned on the Notice, and
    Volkhoff is not appealing a sanctions order against Jane Doe
    entered by the district court.
    We are mindful of Rule 3(c)’s goal of avoiding
    dismissals of appeals solely due to matters of form.
    However, Volkhoff has failed to establish that Rule 3(c)
    forecloses dismissal of this appeal for lack of jurisdiction.
    Because Volkhoff, a nonparty, and Jane Doe, a purported
    appellant not named in the Notice, both fail to meet the
    requirements of appellate jurisdiction, we DISMISS this
    appeal.
    APPEAL DISMISSED.
    

Document Info

Docket Number: 18-55643

Filed Date: 1/2/2020

Precedential Status: Precedential

Modified Date: 1/3/2020

Authorities (22)

Raley Ex Rel. C.G. v. Hyundai Motor Co. , 642 F.3d 1271 ( 2011 )

aetna-life-insurance-company-v-alla-medical-services-inc-management , 855 F.2d 1470 ( 1988 )

Washoe Tribe of Nevada and California v. Joseph Greenley, ... , 674 F.2d 816 ( 1982 )

Securities and Exchange Commission v. Walter Wencke, ... , 783 F.2d 829 ( 1986 )

Lee Argabright Norma J. Argabright v. United States , 35 F.3d 472 ( 1994 )

United States v. John James Badger, Capital Tracing, Inc., ... , 930 F.2d 754 ( 1991 )

American Games, Inc., Intervenor-Appellant v. Trade ... , 142 F.3d 1164 ( 1998 )

Jose Artemio Perez-Martin v. John Ashcroft, Attorney General , 394 F.3d 752 ( 2005 )

In Re Proceedings Before the Federal Grand Jury for the ... , 643 F.2d 641 ( 1981 )

Le v. Astrue , 558 F.3d 1019 ( 2009 )

Citibank International v. Collier-Traino, Inc. v. Umma Bank,... , 809 F.2d 1438 ( 1987 )

Lorraine Detabali v. St. Luke's Hospital John Williams ... , 482 F.3d 1199 ( 2007 )

97-cal-daily-op-serv-5431-97-daily-journal-dar-8805-ralph-w-keith , 118 F.3d 1386 ( 1997 )

southern-california-edison-company-v-loretta-m-lynch-henry-m-duque , 307 F.3d 794 ( 2002 )

Hinck v. United States , 127 S. Ct. 2011 ( 2007 )

United States Ex Rel. Louisiana v. Jack , 37 S. Ct. 605 ( 1917 )

United States of America, Ex rel.linda A. Lujan v. Hughes ... , 243 F.3d 1181 ( 2001 )

retail-flooring-dealers-of-america-inc-a-corporation-donald-ricketts-v , 339 F.3d 1146 ( 2003 )

Marino v. Ortiz , 108 S. Ct. 586 ( 1988 )

Torres v. Oakland Scavenger Co. , 108 S. Ct. 2405 ( 1988 )

View All Authorities »